Evidence map›Paper›PMID 42198760›Full record

ArticleViruses2026

Spent Medium Inhibits rVSV Infection.

Rebecca Habisch, Johannes Georg Wieland, Sophia Kessler, Peter Neubauer, Jorge Soza-Ried, Eva Puschmann

Abstract read
In one paragraph

Article in Viruses, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Rebecca HabischBoehringer Ingelheim, Viral Therapeutics Center, Untere Wiesen 22, D-88416 Ochsenhausen, Germany.ORCID 0009-0005-8682-379X
Johannes Georg WielandBoehringer Ingelheim, Viral Therapeutics Center, Untere Wiesen 22, D-88416 Ochsenhausen, Germany.
Sophia KesslerBoehringer Ingelheim, Viral Therapeutics Center, Untere Wiesen 22, D-88416 Ochsenhausen, Germany.
Peter NeubauerChair of Bioprocess Engineering, Institute of Biotechnology, Technische Universität Berlin, Ackerstr. 76, ACK24, D-13355 Berlin, Germany.ORCID 0000-0002-1214-9713
Jorge Soza-RiedBoehringer Ingelheim, Viral Therapeutics Center, Untere Wiesen 22, D-88416 Ochsenhausen, Germany.
Eva PuschmannBoehringer Ingelheim, Viral Therapeutics Center, Untere Wiesen 22, D-88416 Ochsenhausen, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The cell density effect, defined as reduced cell-specific productivity above a critical cell density, remains a major limitation in virus manufacturing processes. While medium exchange prior to infection has been reported to mitigate this effect, the role of spent medium during the early phase of infection is poorly understood. Here, we show that spent medium conditioned by high-density HEK293 cultures inhibits infection with recombinant vesicular stomatitis virus (rVSV), even when infection is performed at low cell density. The strength of inhibition increased with the density and conditioning time of the donor culture and resulted in slower replication kinetics, thereby delaying the optimal harvest time and potentially reducing overall yield. Notably, the inhibitory effect was reversible when the virus was added to cells maintained in fresh medium, indicating that inhibition is mediated by the medium rather than intrinsic changes in the cells. We excluded pH effects within 7.1-8.0, nutrient depletion, and lactate/ammonium accumulation as primary causes. Removal of cell debris and extracellular vesicles by filtration (down to 0.02 µm) and size-based retention down to 3 kDa did not restore infection, and AUC indicated no major differences in particle distributions between fresh and conditioned media. Together, our data suggest an unidentified <3 kDa inhibitor in spent medium that partially suppresses rVSV infection and slows replication kinetics.

Indexed as

VesiculovirusCulture Media, ConditionedHEK293 CellsHumansVirus InternalizationVirus ReplicationCulture Media, Conditionedattachment and entrycell culturecell density effectinfectionrVSVvirus replication kinetics

Identifiers

PMID42198760
PMCPMC13211489

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.